RecruitingNot ApplicableNCT05991115

Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care

The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care

Sponsor

Kavita Parikh

Enrollment

340 participants

Start Date

Jan 22, 2024

Study Type

INTERVENTIONAL

Conditions

Asthma Asthma in Children

Summary

Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.

Eligibility

Min Age: 4 YearsMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This study is helping families with children who have asthma get better support after a hospital stay. Researchers want to make sure kids don't end up back in the hospital by improving how families manage asthma at home. **You may be eligible if...** - You speak English or Spanish - You are at least 18 years old - You live in Washington DC, Maryland, or Virginia - Your child is between 4 and 12 years old and was just hospitalized for an asthma attack **You may NOT be eligible if...** - Your child has another serious medical condition besides asthma (such as diabetes, heart disease, or a neurological disorder) - Your child is currently in foster care - Your child is already participating in another asthma or behavioral study - You do not live in the DC/Maryland/Virginia area Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHospital to Home Transition (H2H)

The intervention for this study is a multi-component navigation-supported intervention for children hospitalized with asthma. Navigators will work with families for 12-months post-discharge. Trained asthma educator/navigators will work to address challenges with asthma care after discharge; will include maximum 15 contacts/12 months. The asthma navigators within this study will attempt to maintain direct contact with participants primary care doctors through email, fax, and/or postal mail as means for delivering asthma action plans, prescription updates, and patient appointment scheduling. The asthma navigators for intervention participants will attempt to maintain contact with the school nurse in efforts to have a line of communication with the school. Asthma navigators will assist families in all home-based needs pertaining to their child's asthma.

Locations(1)

Children's National Hospital

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05991115

Related Trials

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

NCT06307665135 locations

Personalized Environment and Genes Study

NCT003412371 location

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

NCT073996659 locations

PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

NCT069811693 locations

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589143 locations